RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $378,929 | -30.6% | 45,057 | +3.7% | 0.00% | -33.3% |
| Q2 2023 | $545,795 | -19.3% | 43,455 | +5.8% | 0.00% | -25.0% |
| Q1 2023 | $676,604 | +12.5% | 41,081 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $601,529 | -25.9% | 40,263 | +10.9% | 0.00% | -33.3% |
| Q3 2022 | $812,000 | +35.3% | 36,319 | +1.4% | 0.01% | +50.0% |
| Q2 2022 | $600,000 | -42.3% | 35,807 | +3.1% | 0.00% | -33.3% |
| Q1 2022 | $1,040,000 | -8.9% | 34,738 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $1,142,000 | +10.2% | 37,184 | +13.2% | 0.01% | 0.0% |
| Q3 2021 | $1,036,000 | -13.7% | 32,856 | +0.2% | 0.01% | +50.0% |
| Q2 2021 | $1,200,000 | +29.9% | 32,803 | +22.7% | 0.00% | +33.3% |
| Q1 2021 | $924,000 | +18.8% | 26,725 | +42.8% | 0.00% | 0.0% |
| Q4 2020 | $778,000 | -5.1% | 18,709 | -2.8% | 0.00% | -25.0% |
| Q3 2020 | $820,000 | – | 19,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |